KR101155967B1 - A health food composition for prevention and treatment of allergic rhinitis containing Germanium, elvan and red ginseng Extracts - Google Patents
A health food composition for prevention and treatment of allergic rhinitis containing Germanium, elvan and red ginseng Extracts Download PDFInfo
- Publication number
- KR101155967B1 KR101155967B1 KR1020090086106A KR20090086106A KR101155967B1 KR 101155967 B1 KR101155967 B1 KR 101155967B1 KR 1020090086106 A KR1020090086106 A KR 1020090086106A KR 20090086106 A KR20090086106 A KR 20090086106A KR 101155967 B1 KR101155967 B1 KR 101155967B1
- Authority
- KR
- South Korea
- Prior art keywords
- germanium
- elvan
- allergic rhinitis
- red ginseng
- purified water
- Prior art date
Links
- 201000010105 allergic rhinitis Diseases 0.000 title claims abstract description 50
- 206010039085 Rhinitis allergic Diseases 0.000 title claims abstract description 49
- 229910052732 germanium Inorganic materials 0.000 title claims abstract description 46
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 title claims abstract description 46
- 239000000203 mixture Substances 0.000 title claims abstract description 43
- 235000002789 Panax ginseng Nutrition 0.000 title claims abstract description 34
- 239000000284 extract Substances 0.000 title claims abstract description 33
- 235000013402 health food Nutrition 0.000 title claims abstract description 26
- 230000002265 prevention Effects 0.000 title abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 34
- 239000008213 purified water Substances 0.000 claims abstract description 27
- 239000004480 active ingredient Substances 0.000 claims abstract description 11
- 241000208340 Araliaceae Species 0.000 claims description 25
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 25
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 25
- 235000008434 ginseng Nutrition 0.000 claims description 25
- 239000004575 stone Substances 0.000 claims description 6
- 240000007594 Oryza sativa Species 0.000 claims description 3
- 235000007164 Oryza sativa Nutrition 0.000 claims description 3
- 235000009566 rice Nutrition 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims 2
- 238000000605 extraction Methods 0.000 abstract description 14
- 239000002904 solvent Substances 0.000 abstract description 8
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 abstract description 2
- 229910052709 silver Inorganic materials 0.000 abstract description 2
- 239000004332 silver Substances 0.000 abstract description 2
- 230000006872 improvement Effects 0.000 description 16
- 208000024891 symptom Diseases 0.000 description 14
- 235000013376 functional food Nutrition 0.000 description 13
- 230000036541 health Effects 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 8
- 239000000546 pharmaceutical excipient Substances 0.000 description 8
- 206010041232 sneezing Diseases 0.000 description 7
- 206010020751 Hypersensitivity Diseases 0.000 description 6
- 239000011230 binding agent Substances 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 5
- 210000001331 nose Anatomy 0.000 description 5
- 239000000654 additive Substances 0.000 description 4
- 239000013566 allergen Substances 0.000 description 4
- 229960004784 allergens Drugs 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 206010039083 rhinitis Diseases 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 206010028748 Nasal obstruction Diseases 0.000 description 3
- 208000036071 Rhinorrhea Diseases 0.000 description 3
- 206010039101 Rhinorrhoea Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 239000007884 disintegrant Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 210000002850 nasal mucosa Anatomy 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 238000003359 percent control normalization Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010028735 Nasal congestion Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241000238711 Pyroglyphidae Species 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000748 compression moulding Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- YBMRDBCBODYGJE-UHFFFAOYSA-N germanium oxide Inorganic materials O=[Ge]=O YBMRDBCBODYGJE-UHFFFAOYSA-N 0.000 description 2
- 229940046533 house dust mites Drugs 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 201000009240 nasopharyngitis Diseases 0.000 description 2
- PVADDRMAFCOOPC-UHFFFAOYSA-N oxogermanium Chemical compound [Ge]=O PVADDRMAFCOOPC-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- NZHGWWWHIYHZNX-CSKARUKUSA-N tranilast Chemical compound C1=C(OC)C(OC)=CC=C1\C=C\C(=O)NC1=CC=CC=C1C(O)=O NZHGWWWHIYHZNX-CSKARUKUSA-N 0.000 description 2
- 229960005342 tranilast Drugs 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 241001674044 Blattodea Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010068957 Eosinophilic rhinitis Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- ZCVMWBYGMWKGHF-UHFFFAOYSA-N Ketotifene Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2CC(=O)C2=C1C=CS2 ZCVMWBYGMWKGHF-UHFFFAOYSA-N 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 208000006440 Open Bite Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- SKPPEIDJGJGRGK-UHFFFAOYSA-N Panacen Natural products CCC1=CC=CC2=C1C1OC(C=C=CBr)CC1O2 SKPPEIDJGJGRGK-UHFFFAOYSA-N 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 208000036284 Rhinitis seasonal Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 206010064948 Viral rhinitis Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 201000009151 chronic rhinitis Diseases 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229940124579 cold medicine Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000027326 copulation Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 229960004958 ketotifen Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 208000030247 mild fever Diseases 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000017022 seasonal allergic rhinitis Diseases 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000009329 sexual behaviour Effects 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 208000001319 vasomotor rhinitis Diseases 0.000 description 1
- 230000000280 vitalizing effect Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/304—Foods, ingredients or supplements having a functional effect on health having a modulation effect on allergy and risk of allergy
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 게르마늄, 맥반석 및 홍삼 추출물을 유효성분으로 함유하는 알레르기성 비염의 예방 및 치료용 건강식품조성물에 관한 것으로, 보다 상세하게는, 본 발명에 의한 알레르기성 비염의 예방 및 치료용 건강식품조성물은 정제수와, 게르마늄과, 맥반석과, 홍삼 추출물을 유효성분으로 함유하며, 보다 바람직하게는 상기 정제수와 게르마늄과 맥반석은, 90일 내지 150일 동안 20~30℃에서 숙성된 혼합물로 형성되는 것이 적합하고, 상기 홍삼 추출물은, 정제수와 게르마늄과 맥반석을 혼합하여 90일 내지 150일 동안 20~30℃에서 숙성한 혼합물을 추출용매로 이용하여 25 내지 40시간 동안 70~90℃에서 추출되는 것을 특징으로 한다.The present invention relates to a health food composition for the prevention and treatment of allergic rhinitis containing germanium, elvan and red ginseng extract as an active ingredient, and more particularly, a health food composition for the prevention and treatment of allergic rhinitis according to the present invention. Silver purified water, germanium, elvan and red ginseng extract as an active ingredient, more preferably, the purified water, germanium and elvan is preferably formed in a mixture aged at 20 to 30 ℃ for 90 to 150 days The red ginseng extract is mixed with purified water, germanium and elvan, and extracted at 70 to 90 ° C. for 25 to 40 hours using a mixture aged at 20 to 30 ° C. for 90 to 150 days as an extraction solvent. do.
게르마늄, 맥반서, 홍삼, 알레르기성 비염, 건강식품 Germanium, Macvanseo, Red Ginseng, Allergic Rhinitis, Health Food
Description
본 발명은 게르마늄, 맥반석 및 홍삼 추출물을 유효성분으로 함유하는 알레르기성 비염의 예방 및 치료용 건강식품조성물에 관한 것으로, 보다 상세하게는, 본 발명에 의한 알레르기성 비염의 예방 및 치료용 건강식품조성물은 정제수와, 게르마늄과, 맥반석과, 홍삼 추출물을 유효성분으로 함유하며, 보다 바람직하게는 상기 정제수와 게르마늄과 맥반석은, 90일 내지 150일 동안 20~30℃에서 숙성된 혼합물로 형성되는 것이 적합하고, 상기 홍삼 추출물은, 정제수와 게르마늄과 맥반석을 혼합하여 90일 내지 150일 동안 20~30℃에서 숙성한 혼합물을 추출용매로 이용하여 25 내지 40시간 동안 70~90℃에서 추출되는 것을 특징으로 한다.The present invention relates to a health food composition for the prevention and treatment of allergic rhinitis containing germanium, elvan and red ginseng extract as an active ingredient, and more particularly, a health food composition for the prevention and treatment of allergic rhinitis according to the present invention. Silver purified water, germanium, elvan and red ginseng extract as an active ingredient, more preferably, the purified water, germanium and elvan is preferably formed in a mixture aged at 20 to 30 ℃ for 90 to 150 days The red ginseng extract is mixed with purified water, germanium and elvan, and extracted at 70 to 90 ° C. for 25 to 40 hours using a mixture aged at 20 to 30 ° C. for 90 to 150 days as an extraction solvent. do.
근래에 들어 비염관련 질병이 날로 증가하는 추세에 있는데, 비염은 인체의 호흡기관인 코 내부의 비강점막에 생기는 염증을 일컫는 것으로서, 급성, 만성비염과 감기로 인한 바이러스성 비염 및 알레르기성 비염등이 있다. Recently, rhinitis-related diseases are on the rise, and rhinitis refers to inflammation of the nasal mucosa inside the nose, which is a respiratory organ of the human body, and includes acute, chronic rhinitis, viral rhinitis caused by cold, and allergic rhinitis. .
이 중에 알레르기성 비염은 코 점막이 특정 물질에 대하여 과민반응을 나타 내는 것으로 알레르기를 일으키는 원인 물질(항원)이 코 점막에 노출된 후 자극 부위로 비반세포, 호산구를 비롯한 여러 종류의 IgE 항체를 매개로 하는 염증세포가 몰려들어 이들이 분비하는 다양한 매개물질에 의하여 염증반응이 발생하는 질환이다. 연속적으로 일어나는 발작적인 재채기, 맑은 콧물, 코막힘 등의 세 가지 주요 증상을 특징으로 하며, 이 세 가지 증상 중 두 가지 이상의 증상을 가지고 있을 때 알레르기 비염을 의심할 수 있다. 특징적인 증상 외에도 코 주위 가려움, 두통, 후각 감퇴 등의 증상이 동반될 수 있으며 합병증으로 중이염, 부비동염, 인후두염 등이 동반될 수 있다.Among these, allergic rhinitis is a hypersensitivity reaction to the nasal mucosa, which causes allergens (antigens) to be exposed to the nasal mucosa and mediate various types of IgE antibodies, including apoptotic cells and eosinophils. Inflammatory cells are caused by the inflammatory reactions caused by the various mediators secreted by them. It is characterized by three main symptoms: seizure sneezing, clear runny nose, and stuffy nose, and you may suspect allergic rhinitis when you have two or more of these symptoms. In addition to the characteristic symptoms, it may be accompanied by itching around the nose, headache, and olfactory deterioration. Complications may include otitis media, sinusitis, and pharyngitis.
알레르기성 비염과 구별해야 할 질병으로는 비알레르기성 호산구성 비염, 혈관운동성 비염, 감기 등이 있다. 그 중에서도 일반 환자들이 알레르기성 비염과 가장 혼동하고 있는 질병이 바로 감기이다. 감기에 걸려도 재채기, 콧물 및 코막힘 증상이 다 나타날 수 있기 때문에 일부 사람들은 자신이 감기에 자주 걸리는 체질로 알고 약국에서 감기약을 복용하고 지내는 경우가 많다. 그러나 감기는 대부분 1주 이내에 증상이 호전되나 알레르기 비염은 통상 1~2달 정도 지속이 되고, 감기는 증상이 호전되면 3주 이내에 다시 걸리기가 어려우나 알레르기 비염은 증상이 호전되었다 하더라도 3주 이내에 증상이 다시 나타날 수 있으며, 감기는 미열을 동반하나 알레르기성 비염은 열을 동반하지 않는 특징이 있다. 따라서, 열이 없으면서 감기 증상이 자주 나타나면 알레르기성 비염으로 생각하여야 한다.Diseases to distinguish from allergic rhinitis include non-allergic eosinophilic rhinitis, vasomotor rhinitis, and colds. The most common disease among all patients with allergic rhinitis is cold. Even if you catch a cold, you may have symptoms of sneezing, runny nose and stuffy nose, so some people know that they have a common cold, and often take cold medicine at pharmacies. However, most cases of colds improve within 1 week, but allergic rhinitis usually lasts for 1 to 2 months, and if symptoms improve, it is difficult to catch it again within 3 weeks, but allergic rhinitis develops symptoms within 3 weeks even if symptoms improve. It may reappear, and colds are accompanied by mild fever, but allergic rhinitis is not accompanied by fever. Therefore, if there are no fever and frequent cold symptoms, allergic rhinitis should be considered.
한편, 알레르기 비염의 종류로는 증상의 기간에 따라 연중 짧은 기간에만 발생하는 간헐적(intermittent) 알레르기 비염과 한 달 이상 오랜 기간 발생하는 지 속성(persistent) 알레르기 비염으로 분류하며, 증상의 심한 정도에 따라 경도(mild)와 중등도 중증(moderate severe)으로 분류한다. 또한 어느 특별한 계절에만 발생하는 계절성과 일년 내내 계속 발작하는 통년성으로 나누기도 한다. 계절성 알레르기성 비염은 식물의 꽃가루가 날아다니는 계절과 관련이 있는 경우가 많으나 만성이고 연중 계속되며 계절과 관련없이 통년성으로 발생하기도 한다.On the other hand, allergic rhinitis is classified into intermittent allergic rhinitis that occurs only in a short period of time depending on the duration of symptoms and persistent allergic rhinitis that occurs for a month or more. Classify as mild and moderate severe. It is also divided into seasonality, which occurs only in one particular season, and perennial seizures throughout the year. Seasonal allergic rhinitis is often associated with the season in which pollen is flying, but it is chronic, continues throughout the year, and occurs seasonally regardless of season.
알레르기 비염은 알레르기 천식과 함께 유전적 요인과 환경적 요인이 합쳐져서 생기는 대표적인 알레르기 질환으로, 부모로부터 물려받은 알레르기 체질과 주위의 천식 유발 요소들이 상호 작용을 일으켜 나타난다. 알레르기란 정상에서 벗어난 과민반응을 의미하며 정상인에게는 증상이 유발되지 않지만 알레르기 환자에게는 과민반응으로 여러 증상이 나타나는 것을 말한다. 비염을 악화시키는 대표적인 악화요인은 기후변화, 감기, 공기오염, 스트레스 등으로, 알레르기 비염을 유발하는 원인 항원을 알레르겐이라고도 한다. 집먼지 진드기, 꽃가루, 곰팡이, 애완동물의 털 혹은 비듬, 바퀴벌레 따위의 곤충 부스러기 등과 같이 호흡기를 통해 흡입되는 것들이 대표적이지만, 음식물, 음식물 첨가제, 약물 등에 의해서도 알레르기 비염이 유발될 수 있다. 알레르기에 대한 유전성이 있는 사람 중 얼마나 많은 사람이 알레르기 환자가 되는지는 확실하지 않다. 소아가 아토피 성향을 가지고 있을 때 장기간 항원에 노출된 다음에 증상이 나타나므로 항원에 대한 노출을 피하는 것은 감작이 일어나는 영유아기에 특히 의미가 있다.Allergic rhinitis is a typical allergic disease caused by the combination of genetic and environmental factors along with allergic asthma. Allergy refers to hypersensitivity from the normal and no symptoms occur in normal people, but hypersensitivity reactions to allergy sufferers. Representative exacerbations of rhinitis include climate change, cold, air pollution, stress, and allergens that cause allergic rhinitis. House dust mites, pollen, mold, pet hair or dandruff, cockroaches and other insect inhalation is typical, but food, food additives, drugs, etc. may cause allergic rhinitis. It is not clear how many people with allergies are allergic. Avoiding exposure to antigen is particularly meaningful in infants, where sensitization occurs, as children develop symptoms after prolonged exposure to antigens when they have atopic inclinations.
알레르기 비염의 치료는 원인이 되는 물질인 집먼지 진드기, 꽃가루, 애완동물의 털, 곤충, 곰팡이 등의 알레르겐(항원)과 담배연기, 실내 오염물질, 기후변 화, 악화약물, 스트레스 등의 악화요인을 피하는 환경요법(회피요법)과 먹거나 코에 뿌리는 약물을 사용하는 약물요법, 항원을 규칙적인 간격으로 투여해 면역을 기르는 면역요법이 있다. 알레르겐을 피하는 것이 가장 중요한 치료법이지만 근본적으로 피하는 것은 현실적으로 어렵기 때문에 회피요법 단일 치료만으로는 충분한 치료 효과를 얻기 어려우며 적절한 약물치료로 증상을 조절하는 것이 필요하다.Treatment of allergic rhinitis can cause allergens (antigens) such as house dust mites, pollen, pet hair, insects, and fungi, and tobacco smoke, indoor pollutants, climate change, worsening drugs, and stress. There are environmental therapies (avoidance therapy), drug therapies that use eating or nasal sprays, and immunotherapy that raises immunity at regular intervals. Avoiding allergens is the most important treatment, but fundamentally difficult to avoid, it is difficult to obtain sufficient therapeutic effect with avoidance therapy alone, and it is necessary to control symptoms with proper medication.
그러나, 상기 요법들로 완전한 치료를 한다는 것은 매우 어려운 실정이며, 또한 알레르기성 비염 치료를 위하여 주로 사용하고 있는 트라닐라스트, 케토티펜 등의 화학물질은 독성이 심하여 소화장애, 어지러움증 및 속쓰림 등의 부작용을 유발시키고, 게다가 장기적으로 복용할 경우 내성을 생기게 하여 알레르기성 비염을 만성화시키는 문제점을 갖는다.However, it is very difficult to complete the treatment with the above therapies, and chemicals such as tranilast and ketotifen, which are mainly used for the treatment of allergic rhinitis, are highly toxic, such as digestive disorders, dizziness, and heartburn. In addition to causing side effects, and in addition to long-term tolerant to cause allergic rhinitis has a problem.
따라서, 보다 간편하고 효과적으로 평소 섭취할 수 있는 음식물을 통하여 알레르기성 비염을 예방 또는 치료할 수 있는 건강식품조성물이 필요하다.Therefore, there is a need for a health food composition that can prevent or treat allergic rhinitis through food that can be easily and effectively consumed.
본 발명은 상술한 문제점을 해결하기 위하여 안출된 것으로, 본 발명은 알레르기성 비염을 예방 및 치료하기 위하여 게르마늄, 맥반석 및 홍삼추출물을 유효성분으로 함유하는 알레르기성 비염의 예방 및 치료용 건강식품조성물을 제공함을 목적으로 한다.The present invention has been made to solve the above problems, the present invention is to prevent and treat allergic rhinitis health food composition for the prevention and treatment of allergic rhinitis containing germanium, ganban stone and red ginseng extract as an active ingredient For the purpose of providing it.
상술한 과제를 해결하기 위하여 본 발명은 다음과 같은 수단을 포함할 수 있다.In order to solve the above problems, the present invention may include the following means.
본 발명의 일 실시예에 따른 알레르기성 비염의 예방 및 치료용 건강식품조성물은, 정제수와, 게르마늄과, 맥반석과, 홍삼 추출물을 유효성분으로 함유한다.Health food composition for the prevention and treatment of allergic rhinitis according to an embodiment of the present invention, purified water, germanium, elvan, red ginseng extract as an active ingredient.
본 발명의 다른 실시예에 따른 알레르기성 비염의 예방 및 치료용 건강식품조성물에 있어서, 정제수는 1000~2000g, 게르마늄은 50~100g, 맥반석은 50~100g, 홍삼 추출물은 300~600g 으로 형성되는 것을 특징으로 한다.In the health food composition for preventing and treating allergic rhinitis according to another embodiment of the present invention, purified water is 1000 ~ 2000g, germanium is 50 ~ 100g, ganban stone is 50 ~ 100g, red ginseng extract is formed to 300 ~ 600g It features.
본 발명의 또 다른 실시예에 따른 알레르기성 비염의 예방 및 치료용 건강식품조성물에 있어서, 상기 홍삼 추출물은, 정제수와 게르마늄과 맥반석을 혼합하여 90일 내지 150일 동안 20~30℃에서 숙성한 혼합물을 추출용매로 이용하여 25 내지 40시간 동안 70~90℃에서 추출되는 것을 특징으로 한다.In the health food composition for the prevention and treatment of allergic rhinitis according to another embodiment of the present invention, the red ginseng extract, a mixture of purified water, germanium and elvan, aged at 20 ~ 30 ℃ for 90 days to 150 days It is characterized in that it is extracted at 70 ~ 90 ℃ for 25 to 40 hours using an extraction solvent.
본 발명의 또 다른 실시예에 따른 알레르기성 비염의 예방 및 치료용 건강식품조성물에 있어서, 상기 정제수와 게르마늄과 맥반석은, 90일 내지 150일 동안 20~30℃에서 숙성된 혼합물로 형성되는 것을 특징으로 한다.In a health food composition for preventing and treating allergic rhinitis according to another embodiment of the present invention, the purified water, germanium, and elvan are formed in a mixture aged at 20 to 30 ° C. for 90 to 150 days. It is done.
본 발명은 알레르기성 비염을 예방 및 치료하기 위하여 게르마늄, 맥반석 및 홍삼추출물을 유효성분으로 함유하는 알레르기성 비염의 예방 및 치료에 탁월한 효과를 제공한다. The present invention provides an excellent effect in the prevention and treatment of allergic rhinitis containing germanium, elvan and red ginseng extract as active ingredients in order to prevent and treat allergic rhinitis.
이하, 본 발명을 구체적으로 설명한다.Hereinafter, the present invention will be described in detail.
본 발명에 따른 알레르기성 비염의 예방 및 치료용 건강식품조성물은 정제수와, 게르마늄과, 맥반석과 홍삼추출물을 유효성분으로 함유한다.Health food composition for the prevention and treatment of allergic rhinitis according to the present invention contains purified water, germanium, elvan and red ginseng extract as an active ingredient.
본 발명에서 이용되는 게르마늄은 32개의 전자를 가지는 원자번호 32의 원자로서, 그 최외각 궤도에는 4개의 전자가 배치되어 있으며, 그 안의 1개의 전자는 대단히 유리하기 쉬운 성질을 가지며, 이 한개의 전자가 유리하면 최외각궤도에 정공(正孔)이 생겨 이 정공을 막기 위해 밖으로부터 다른 전자를 흡인하는 성질을 가지며, 한편 생체의 신경계는 생체내에 생기는 전기적 작용에 의해 정상적인 기능이 유지되도록 되어 있으나, 생체중에 있어서 여러가지의 환부에 있어서는 각 세포의 전위가 상이한 값을 표시하는 것이 알려져 있으며, 본 발명에 이용되는 게르마늄은 다양한 게르마늄을 사용할 수 있으며, 바람직하게는 산삼, 인삼 등의 식물에서 추출된 유기 게르마늄이 적합하다. 일본의 아사이 가쓰꼬 박사가 석탄에서 추출한 산화게르마늄을 수소로 환원시켜 게르마늄의 결정을 만들고, 이것을 기초로 하여 많은 연구를 통해 물에 용해되는 유기 게르마늄 및 아미노산 게르마늄을 최초로 합성 하는데 성공하였고, 이를 "Ge-132" 및 에이.지.오(AGO ; Aminoacid Germanium Oxide)라 명명되었고, 상기 유기 게르마늄의 정식 명칭은 칼복시 에칠 게르마늄 세시큐옥사이드(Bis. P-Carboxyethyl Germanium Sesquioxide)라 한다. 한편, 게르마늄에 의한 약리작용은 아직 충분하게는 해명되어 있지 않으나, 게르마늄이 갖는 이온발생효과, 래디칼 소거효과 등의 전기적 특성에 의해 환부와의 사이에서 전자교환등이 행하여져서, 환부의 이상전위가 정상화되어서 혈압의 조정작용, 항암작용, 유발작용을 하는 것으로 판단되고, 게르마늄이 많이 들어 있는 식물로는 산삼, 인삼, 영지, 마늘, 컴프리, 알로에 등을 들 수 있다.Germanium used in the present invention is an atom of atomic number 32 having 32 electrons, and four electrons are arranged in the outermost orbit, and one electron therein has a property that is very advantageous. If it is advantageous, holes are generated in the outermost orbit, which has the property of attracting other electrons from the outside to block the holes, while the nervous system of the living body is maintained to maintain its normal function by the electrical action occurring in the living body. It is known that the potential of each cell shows a different value in various affected areas in the living body, and germanium used in the present invention may use various germanium, preferably organic germanium extracted from plants such as wild ginseng and ginseng. This is suitable. Dr. Atsugi Katsuko of Japan reduced the germanium oxide extracted from coal to hydrogen to make germanium crystals. Based on this, many studies have succeeded in the first synthesis of organic germanium and amino acid germanium dissolved in water. -132 "and AGO (Aminoacid Germanium Oxide), and the official name of the organic germanium is Bis. P-Carboxyethyl Germanium Sesquioxide (Bis. P-Carboxyethyl Germanium Sesquioxide). On the other hand, the pharmacological action by germanium is not yet fully understood, but due to the electrical properties such as the ion generating effect and the radical scavenging effect of germanium, electron exchange is performed between the affected part and the abnormal potential of the affected part is reduced. It is judged to have normalized blood pressure adjustment, anticancer action, and induced action, and plants containing a lot of germanium include wild ginseng, ginseng, ganoderma lucidum, garlic, comfrey, and aloe.
본 발명에서 이용되는 맥반석은 화성암류 중 석영반암에 속하는 암석으로, 무수 규산(SiO2)과 산화 알루미늄(Al2O3)이주성분이고, 인체와 살아있는 세포에 꼭 필요한 산화 제2철(Fe2O3)을 함유하고 있으며, 40여종의 각종 미네랄 원소를 함유하고, 1㎤ 당 3만개 내지 15만개의 많은 공극을 포함하고 있다. 이러한 맥반석은, 생체 발육과 생리 기능 조절, 세포의 활력 유지, 생육 촉진 등의 작용을 한다. 맥반석의 이러한 효과는, 실생활에서 쉽게 발견할 수 있는데, 예를들어, 맥반석을 사용한 수족관, 어항 및 양어장 등은 뛰어난 수질 조절 기능으로 수질 향상 효과를 얻고 있고, 또한, 맥반석은 중금속 분해 작용으로, 1㎤ 당 3만개 이상의 다층 다공질로 이루어져 있어 비표면적이 넓기 때문에 모세관 현상을 이용해서 중금속, 오염 물질 등을 흡착, 분해하는 작용을 한다. 또한, 맥반석은 미네랄 용출 작용으로, 인체에 활력을 주는 약 40종의 미네랄이 용해되어 있으므로, 신진대사와 피부 건강 관리에 효과가 있고, 모든 암석은 미네랄 성분을 함유하고는 있지만, 맥반석의 경우에는 일반적으로 알려져 있는 미네랄 뿐만 아니라, 현대 과학으로는 해명되지 않는 유효 미네랄도 용출하는 것이 특징이다. 나아가, 맥반석은 풍부한 산소 함유량으로, 맥반석을 물에 넣으면 화학적 산소 요구량 (COD), 생물학적 산소 요구량 (BOD)이 낮아져서 방부 작용과 함께 생체에 활력을 주는 작용을 하고, 원적외선 발생, 방사 작용으로서, 공명, 흡수 작용 등으로 식품의 신선도를 유지하고, 맛을 좋게 하며, 혈액 순환을 촉진시키는 작용을 하며, 맥반석이 방출하는 원적외선은 피부 40 내지 50mm 안으로 깊숙이 침투해서 세포를 활성화하고 혈액 순환을 촉진하며, 노폐물 등을 체외로 배출시킨다.A rock elvan used in the present invention belong to the quartz porphyry of igneous acids, silica (SiO 2) and aluminum oxide (Al 2 O 3) migratory minutes, and means oxidation required for the human body and living cells ferric (Fe 2 O 3 ) containing about 40 kinds of various mineral elements, and containing 30,000 to 150,000 many voids per cm 3. These elvan stones act to regulate biological growth and physiological function, maintain vitality of cells, and promote growth. These effects of elvan can be easily found in real life. For example, aquariums, fish tanks, and fish farms using elvan have been able to improve water quality with excellent water quality control. Since it consists of more than 30,000 multi-layered porous materials per cm 3, it has a large specific surface area, which uses capillary action to adsorb and decompose heavy metals and contaminants. In addition, since elvan has dissolved about 40 kinds of minerals that give vitality to the human body, it is effective for metabolism and skin health care. All rocks contain minerals, but in the case of elvan It is characterized by eluting not only minerals generally known but also effective minerals which are not explained by modern science. Furthermore, the elvan has abundant oxygen content, and when the elvan is put in water, the chemical oxygen demand (COD) and biological oxygen demand (BOD) are lowered, thereby acting as an antiseptic action and vitalizing the living body, generating far infrared rays, and radiating the resonance. It maintains the freshness of food, improves taste, and promotes blood circulation by absorbing, and far infrared rays emitted by ganbanite penetrate deeply into the skin 40-50mm to activate cells and promote blood circulation, Waste products are discharged outside the body.
본 발명에서 이용되는 게르마늄 및 맥반석은 정제수 1000~2000g 당 게르마늄 50~100g, 맥반석은 50~100g 혼합되는 것을 특징으로 한다. 바람직하게는 상기 게르마늄과 맥반석은 정제수 1000~2000g 당 게르마늄 50~100g, 맥반석 50~100g을 혼합하여 90일 내지 150일 동안 20~30℃에서 공지의 방법으로 숙성하여 형성된 혼합물을 이용하는 것이 알레르기성 비염의 예방 및 치료를 좋게 하기 위하여 적합하다.Germanium and ganbanite used in the present invention is characterized in that 50 to 100g of germanium per 50 to 2000g of purified water, and 50 to 100g of ganbanite are mixed. Preferably, the germanium and the elvan are mixed with 50 to 100 g of germanium per 50 to 2000 g of purified water and 50 to 100 g of elvan, and aged at 20 to 30 ° C. for 90 days to 150 days using a mixture formed by a known method for allergic rhinitis. It is appropriate to improve the prevention and treatment of the.
본 발명에서 이용되는 홍삼(Red Ginseng)은 인삼산업법에 따르면, "말리지 아니한 인삼, 즉 수삼을 증기 또는 기타 방법으로 쪄서 익혀 말린 것을 말한다"라고 정의하고 있다. 홍삼의 중요 성분으로는 백삼과 같이 배당체(glycosides)?인삼향성분(panacen)?폴리아세틸렌계 화합물?함질소성분 ?플라보노이드?비타민(B군)?미량원소?효소?항산화물질과 유기산 및 아미노산 등이 함유되어 있고, 특히 사포닌과 게르마늄이 많이 함유되어 있다. 홍삼은 중추신경에 대해서 진정작용과 흥분작용이 있으며, 순환계에 작용하여 고혈압이나 동맥경화의 예방효과가 있다. 그러면서도 조혈작용(造血作用)과 혈당치(血糖値)를 저하시켜 주고, 간을 보호하며, 내분비계에 작용하여 성행동(性行動)이나 생식효과에 간접적으로 유효하게 작용하며, 항종양작용(抗腫瘍作用)이 있고, 방사선에 대한 방어효과, 피부를 보호하며 부드럽게 하는 작용도 있다.Red ginseng (Red Ginseng) used in the present invention is defined according to the ginseng industry law, "not dried ginseng, that is, means steamed and dried by steam or other methods". The main components of red ginseng are glycosides, ginseng fragrances (panacen), polyacetylene-based compounds, nitrogen-containing components, flavonoids, vitamins (group B), trace elements, enzymes, antioxidants, organic acids and amino acids. Is contained, and especially saponin and germanium are contained a lot. Red ginseng has a sedative and arousing effect on the central nervous system, and it acts on the circulatory system to prevent hypertension or atherosclerosis. At the same time, hematopoietic effect (造血 作用) and blood sugar levels (저하) lowers, protects the liver, acts on the endocrine system indirectly effective on sexual behavior and reproductive effects, anti-tumor action (抗)腫 瘍 作用) has a protective effect against radiation, and protects and softens the skin.
한편, 홍삼의 일반적인 제조과정은 수삼 또는 건삼을 물로 깨끗하게 씻고, 일정한 용기에 넣어 가열된 수증기를 이용하여, 크기에 따라 일정시간 찐다(蒸蔘). 증삼된 것은 1차 열풍건조 후부터는 태양열을 이용하거나 기타 방법으로 수분이 12.5~13.5% 정도 될 때까지 건조하며 잔뿌리(홍미삼)를 따내고 모양을 가다듬어(胴體), 등급별로 선별하여 같은 등급은 개체의 크기와 중량별로 선별하며 템프레타관(罐)에 진공포장한다.On the other hand, the general manufacturing process of red ginseng wash the fresh ginseng or dry ginseng with water, and steamed for a predetermined time depending on the size by using a heated steam in a predetermined container. Dried ginseng is dried by solar heat or other method until 12.5 ~ 13.5% of moisture after primary hot air drying. The fine roots are removed and the shape is refined. It is sorted by size and weight, and vacuum-packed in temper tube.
본 발명에서 이용되는 홍삼 추출물은 널리 쉽게 구입할 수 있는 홍삼 뿐만 아니라 공지된 다양한 방법으로 홍삼에서 추출되는 추출물을 포함하는 것으로서, 공지의 홍삼추출물을 이용할 수 있으나, 바람직하게는 하기와 같은 방법으로 수득될 수 있다. The red ginseng extract used in the present invention includes not only red ginseng which can be easily purchased as well as extracts extracted from red ginseng by various known methods, but well-known red ginseng extracts can be used, but preferably obtained by the following method. Can be.
먼저, 건삼, 미삼, 또는 수삼 등의 인삼을 각각 물로 깨끗이 세척한 후, 그늘에서 건조한다. 건조한 인삼을 추출용기에 넣고, 적당량의 추출용매에 적절한 온도에서 일정 시간 추출한다. 추출물은 여과되고, 진공회전증발기 등을 이용하여 농축될 수 있다.First, ginseng such as dried ginseng, rice ginseng, or fresh ginseng is washed with water, and then dried in the shade. Dry ginseng is placed in an extraction container and extracted for a certain period of time at an appropriate temperature in an appropriate amount of extraction solvent. The extract can be filtered and concentrated using a vacuum rotary evaporator or the like.
상기 추출 용매로는 물(정제수), 탄소수 1 내지 4의 저급 알콜 또는 이들의 혼합 용매로부터 선택된 극성용매를 사용할 수 있으나, 바람직하게는 알레르기성 비염 및 치료의 극대화를 위하여, 정제수 1000~2000g 당 게르마늄 50~100g, 맥반석은 50~100g 혼합되어 90일 내지 150일 동안 20~30℃에서 공지의 방법으로 숙성하여 형성된 혼합물을 사용하는 것이 적합하다.As the extraction solvent, a polar solvent selected from water (purified water), a lower alcohol having 1 to 4 carbon atoms or a mixed solvent thereof may be used. Preferably, in order to maximize allergic rhinitis and treatment, germanium per 1000 to 2000 g of purified water may be used. 50-100 g, elvan is 50-50 g mixed, it is suitable to use the mixture formed by aging by a known method at 20 ~ 30 ℃ for 90 to 150 days.
상기 추출 용매의 양은 건삼, 미삼, 또는 수삼 등의 인삼 건조 중량의 2 ~ 10 배로 한다.The amount of the extraction solvent is 2 to 10 times the dry weight of ginseng such as dried ginseng, rice ginseng, or fresh ginseng.
상기 추출 방법은 중탕 추출, 환류냉각 추출, 초음파 추출 등의 추출 방법을 사용할 수 있으며, 바람직하게는 중탕 추출의 추출방법으로 1회 내지 5회 추출될 수 있다.The extraction method may be an extraction method such as hot water extraction, reflux cooling extraction, ultrasonic extraction, etc., and may be extracted once to five times, preferably as an extraction method of hot water extraction.
상기 추출온도는 70~90℃ 가 바람직하며, 추출시간은 25 ~ 40 시간이 적합하다.The extraction temperature is preferably 70 ~ 90 ℃, the extraction time is suitable 25 to 40 hours.
상기 추출물을 수득한 후, 거름종이 등을 이용하여 고형분을 제거하고, 현탁액을 원심분리 시키고, 상층액을 감압여과할 수 있다.After the extract is obtained, solids are removed using a filter paper, the suspension is centrifuged, and the supernatant can be filtered under reduced pressure.
상기 여과된 추출물을 진공회전농축기로 20 ~ 100℃, 바람직하게는 50 ~ 70℃에서 감압농축할 수 있다.The filtered extract can be concentrated under reduced pressure at 20 ~ 100 ℃, preferably 50 ~ 70 ℃ with a vacuum rotary concentrator.
또한, 본 발명의 추출물은 상술한 추출 용매에 의한 추출물뿐만 아니라, 통상적인 정제 과정을 거친 추출물도 포함한다. 예컨대, 일정한 분자량 컷-오프 값을 갖는 한외여과막을 이용한 분리, 다양한 크로마토그래피 (크기, 전하, 소수성 또는 친화성에 따른 분리를 위해 제작된 것)에 의한 분리 등, 추가적으로 실시된 다양한 정제 방법을 통해 얻어진 분획도 본 발명의 추출물에 포함되는 것이다.In addition, the extract of the present invention includes not only the extract by the above-described extraction solvent, but also the extract that has undergone a conventional purification process. Obtained by various additional purification methods, such as, for example, separation using ultrafiltration membranes having a constant molecular weight cut-off value, separation by various chromatography (manufactured for separation according to size, charge, hydrophobicity or affinity). The fraction is also included in the extract of the present invention.
본 발명의 추출물은 감압 증류 및 동결 건조 또는 분무 건조 등과 같은 추가적인 과정에 의해 분말 상태로 제조될 수 있다. Extracts of the present invention may be prepared in powder form by additional processes such as distillation under reduced pressure and freeze drying or spray drying.
본 발명에 따른 건강식품조성물은 정제수와 게르마늄과, 맥반석과, 홍삼추출물을 유효성분으로 함유하여 알레르기성 비염을 예방 및 치료함을 하기의 실험예에 의해서 확인할 수 있다.Health food composition according to the present invention can be confirmed by the following experimental example to prevent and treat allergic rhinitis by containing purified water and germanium, elvan, red ginseng extract as an active ingredient.
한편, 본 발명에 따른 알레르기성 비염의 예방 및 치료용 건강식품 조성물은 정제수 1000~2000g 당, 게르마늄 50~100g, 맥반석 50~100g, 홍삼 추출물 300~600g 으로 형성되는 것이 적합하고, 상기 정제수와 게르마늄과 맥반석은, 90일 내지 150일 동안 20~30℃에서 숙성된 혼합물로 형성되는 것이 보다 바람직하다.On the other hand, the health food composition for the prevention and treatment of allergic rhinitis according to the present invention is preferably formed of purified water 1000 ~ 2000g, germanium 50 ~ 100g, ganban stone 50 ~ 100g, red ginseng extract 300 ~ 600g, the purified water and germanium More preferably, the elvan is formed into a mixture aged at 20 to 30 ° C. for 90 to 150 days.
또한, 또한 본 발명에 따른 건강식품조성물은 알레르기성 비염의 치료 및 예방을 위한 목적으로 정제, 캅셀, 분말, 과립, 액상, 환 등의 형태의 건강기능식품으로 제조 및 가공이 가능하다.In addition, the health food composition according to the present invention can be manufactured and processed into a health functional food in the form of tablets, capsules, powders, granules, liquids, pills and the like for the purpose of the treatment and prevention of allergic rhinitis.
예를 들어, 상기 정제 형태의 건강식품조성물은 그대로 또는 부형제, 결합제, 붕해제 또는 다른 첨가제를 넣어 고르게 섞은 것을 적당한 방법으로 과립상으로 한 다음 활택제 등을 넣어 압축성형하여 조제하거나 정제 형태의 건강기능식품을 그대로 또는 부형제, 결합제, 붕해제 또는 다른 적당한 첨가제를 넣어 고르게 섞은 것을 직접 압축성형하여 만들거나 또는 미리 만든 과립에 건강기능식품을 그대로 혹은 적당한 첨가제를 넣어 고르게 섞은 음 압축성형하여 조제하거나 건강기능식품에 부형제, 결합제 또는 다른 적당한 첨가제를 넣어 고르게 섞은 분말을 용매로 습윤시키고, 습윤된 분말을 저압으로 틀에넣어서 성형한 후, 적당한 방법으로 건조하여 조제한다. 또한, 상기 정제 형태의 건강기능식품에 필요에 따라 교미제 등을 넣을 수 있으며, 적당한 제피제로 제피 가능하다.For example, the health food composition in the form of tablets may be prepared as it is or granularly mixed with an excipient, a binder, a disintegrating agent or other additives in a suitable manner, and then compressed into a glidant or the like, or prepared in a tablet form. Prepare functional foods by directly compression molding them as they are, or by mixing them evenly with excipients, binders, disintegrants or other suitable additives, or by negative compression molding the health foods as they are or evenly added with appropriate additives. The excipient, binder or other suitable additives are added to the functional food, and the mixed powder is wetted with a solvent, the wet powder is molded into a mold at low pressure, and then dried and prepared by a suitable method. In addition, the nutraceutical can be added to the health functional food in the form of tablets, if necessary, can be avoided with a suitable epidermis.
상기 캅셀 형태의 건강기능식품 중 경질캅셀제는 보통 캅셀에 건강기능식품 또는 건강기능식품에 적당한 부형제 등을 고르게 섞은 것 또는 적당한 방법으로 입상으로 한 것 또는 입상으로 한 것에 적당한 제피제로 제피한 것을 그대로 또는 가볍게 성형하여 충전하여 조제하며, 연질캅셀제는 보통 캅셀에 건강기능식품 또는 건강기능식품에 적당한 부형제 등을 넣은 것을 젤라틴 등 적당한 캅셀기제에 글리세린 또는 소르비톨 등을 넣어 소성을 높인 캅셀기제로 피포하여 일정한 형상으로 성형하여 조제하며, 필요에 따라 상기 캅셀기제에 착색료 보존료 등을 첨가할 수 있다.Among the health functional foods in the form of capsules, the hard capsules are usually prepared by mixing the capsules evenly with the health functional foods or excipients suitable for the health functional foods, granulated by a suitable method, or granulated with a suitable epidermal agent as it is or Soft capsules are prepared by filling them, and soft capsules are usually filled with capsules containing glycerin or sorbitol in a capsule form containing gelatin or appropriate excipients suitable for health functional foods or health functional foods. It is molded and prepared, and a coloring agent preservative etc. can be added to the said capsule base as needed.
환형태의 건강기능식품은 보통 건강기능식품에 부형제, 결합제, 붕해제 등을 고르게 섞은 다음 적당한 방법으로 구상으로 성형하여 조제하며, 필요에 따라 백당이나 다른 적당한 제피제로 제피를, 또는 전분, 탈크 또는 적당한 물질로 환의를 입힐 수도 있다.Circular functional foods are usually mixed with excipients, binders, disintegrants, etc., and then molded into a spherical form in a suitable manner, and the coating is carried out with white sugar or other suitable coating agent, or starch, talc or You can also be greeted with a suitable substance.
과립형태의 건강기능식품은 보통 건강기능식품을 그대로 또는 건강기능식품에 부형제, 결합제, 붕해제 등을 넣어 고르게 섞은 다음 적당한 방법으로 입상으로 만들고 될 수 있는 대로 입자를 고르게 한 것이며, 필요에 따라 착향료, 교미제 등을 넣을 수 있다. 과립형태의 건강기능식품은 12호 (1680 μm), 14호 (1410 μm) 및 45호 (350 μm) 체를 써서 다음 입도시험을 할 때에 12호체를 전량 통과하고 14호체에 남는 것은 전체량의 5.0 %이하이고 또 45호체를 통과하는 것은 전체량의 15.0 %이하이어야 한다.The health functional food in the form of granules is usually made by mixing the health functional food as it is or by adding excipients, binders, disintegrating agents, etc., evenly and then granulating it in a proper way to make the particles as even as possible. , Mating agent, etc. can be added. For the health functional food in the form of granules, No. 12 (1680 μm), No. 14 (1410 μm) and No. 45 (350 μm) are used for the next particle size test. It should be less than 5.0% and pass through No.45 to less than 15.0% of the total amount.
본원 발명의 상기 부형제, 결합제, 붕해제, 활택제, 교미제, 착향료 등에 대한 용어 정의는 당업계에 공지된 문헌에 기재된 것으로 그 기능 등이 동일 내지 유사한 것들을 포함한다 (대한약전 해설편, 문성사, 한국약학대학협의회, 제 5 개정판, p33-48, 1989 ).The term definitions of the excipients, binders, disintegrants, lubricants, copulation agents, flavoring agents, etc. of the present invention are described in documents known in the art and include those having the same or similar functions. , Korean College of Pharmacy, 5th Edition, p33-48, 1989).
이하, 실시예와 실험예를 통하여 본 발명을 더욱 상세히 설명 하고자 한다. 하기, 실시예와 실험예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로서, 본 발명의 요지에 따라 본 발명의 범위가 이들에 의해 제한되지 않는다는 것은 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail with reference to Examples and Experimental Examples. The following Examples and Experimental Examples are only for more specifically describing the present invention, and the scope of the present invention is not limited by them according to the gist of the present invention. It will be obvious to him.
[실시예][Example]
게르마늄 50g과 맥반석 50g 을 정제수 1000g 에 혼합하여 90일 동안 25℃에서 숙성시킨 혼합물을 제조하였다. 상기 숙성된 혼합물에 깨끗이 세척한 건삼 400g을 침지한 후 85℃에서 30시간 동안 찐 후에 여과하여 홍삼(또는, 홍삼추출물)을 수득하였다. 수득된 홍삼 400g을 세절하여 게르마늄 50g과 맥반석 50g을 정제수 1000g 에 혼합하여 90일 동안 25℃에서 숙성시킨 혼합물에 10시간 침지한 후에 액상의 건강식품조성물을 얻었다.50 g of germanium and 50 g of elvan were mixed with 1000 g of purified water to prepare a mixture aged at 25 ° C. for 90 days. After immersing 400 g of the dried ginseng washed thoroughly in the matured mixture and steamed for 30 hours at 85 ℃ to obtain red ginseng (or red ginseng extract). 400 g of the red ginseng obtained was cut into pieces, and 50 g of germanium and 50 g of ganbanite were mixed with 1000 g of purified water, and then immersed in a mixture aged at 25 ° C. for 10 days for 10 hours to obtain a liquid health food composition.
[실험예 1]알레르기 비염에 대한 임상효과 실험Experimental Example 1 Clinical Effect Experiment on Allergic Rhinitis
상기 실시예에 따라 얻어진 건강식품조성물을 이용하여 알레르기성 비염의 대표적인 증상인 재채기, 비폐색, 비즙의 증상을 보이는 알레르기성 비염 환자들 중에서 20~50대 연령층의 남녀 50명을 무작위로 하여 임상실험을 하였다. 실험방법 은 실험군으로 총 4주 동안 1일 2회 아침, 저녁으로 100ml씩 상기 실시예에 따라 얻어진 건강식품조성물을 복용하게 한 다음 재채기, 비즙, 비폐색에 대한 결과를 점검하였다. 또한, 대조군으로 알레르기성 비염 환자들 중에서 20~50대 연령층의 남녀 50명에게 알레르기성 비염에 사용하는 경구용 약제인 트라닐라스트(tranilast)를 1일 2회 아침, 저녁으로 100ml씩을 복용하게 한 다음 재채기, 비즙, 비폐색에 대한 결과를 점검하였다.Using a health food composition obtained according to the above example, among allergic rhinitis patients showing symptoms of sneezing, nasal obstruction, and nasal juice, which are typical symptoms of allergic rhinitis, 50 men and women of 20 to 50 age groups were randomly tested. It was. Experimental method was to take the health food composition obtained according to the above example 100ml each morning, evening twice a day for a total of four weeks in the experimental group and then checked the results for sneezing, nasal juice, nasal obstruction. In addition, as a control group, 50 men and women of allergic rhinitis patients were given 100ml of tranilast, an oral drug used for allergic rhinitis, twice a day in the morning and evening. The results were then checked for sneezing, nasal juice and nasal obstruction.
증상의 정도는 하기의 표 1과 같은 기준으로 하였고, 그 개선 결과는 하기 표 2내지 4에 나타내었다.The degree of symptoms was based on the same criteria as Table 1 below, and the improvement results are shown in Tables 2 to 4 below.
(하루 횟수)Sneezing attack
(Day times)
(하루의 콧물 닦는 수)Non-juice
(Can be runny nose of the day)
(본발명의조성물)Experimental group
Composition of the Invention
(트라닐라스트)Control
(Trianilast)
상기 표 2에 의하면, 본 발명의 조성물을 복용한 실험군의 재채기에 대한 개선율은 98%의 개선율을 보였으며, 특히 매우 좋아졌다와 좋아졌다에 해당하는 개선율이 80% 에 해당함을 확인할 수 있는 바 본 발명에 따른 건강식품조성물은 알레르기 비염의 치료에 탁월한 효과가 있음을 확인할 수 있었다.According to Table 2, the improvement rate for the sneeze of the experimental group taking the composition of the present invention showed an improvement rate of 98%, especially the improvement rate corresponding to the very good and improved the bar can be confirmed that 80% Health food composition according to the invention was confirmed to have an excellent effect in the treatment of allergic rhinitis.
(본발명의조
성물)Experimental group
(Article of the Invention)
Relics
(트라닐라스
트)Control
(Tranillas
T)
상기 표 3에 의하면, 본 발명의 조성물을 복용한 실험군의 비즙에 대한 개선율은 100%의 개선율을 보였으며, 특히 매우 좋아졌다와 좋아졌다에 해당하는 개선율이 90% 에 해당함을 확인할 수 있는 바 본 발명에 따른 건강식품조성물은 알레르기 비염의 치료에 탁월한 효과가 있음을 확인할 수 있었다.According to Table 3, the improvement rate for the nasal juice of the experimental group taking the composition of the present invention showed an improvement rate of 100%, especially the improvement rate corresponding to the very good and improved bar 90 can be confirmed that Health food composition according to the invention was confirmed to have an excellent effect in the treatment of allergic rhinitis.
(본발명의조
성물)Experimental group
(Article of the Invention)
Relics
(트라닐라스
트)Control
(Tranillas
T)
상기 표 4에 의하면, 본 발명의 조성물을 복용한 실험군의 비폐색에 대한 개선율은 90%의 개선율을 보였으며, 특히 매우 좋아졌다와 좋아졌다에 해당하는 개선율이 68% 에 해당함을 확인할 수 있는 바 본 발명에 따른 건강식품조성물은 알레르기 비염의 치료에 탁월한 효과가 있음을 확인할 수 있었다.According to the Table 4, the improvement rate for the non-occluded of the experimental group taking the composition of the present invention showed an improvement rate of 90%, especially it can be confirmed that the improvement rate corresponding to 68% is very good and good Health food composition according to the invention was confirmed to have an excellent effect in the treatment of allergic rhinitis.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090086106A KR101155967B1 (en) | 2009-09-11 | 2009-09-11 | A health food composition for prevention and treatment of allergic rhinitis containing Germanium, elvan and red ginseng Extracts |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090086106A KR101155967B1 (en) | 2009-09-11 | 2009-09-11 | A health food composition for prevention and treatment of allergic rhinitis containing Germanium, elvan and red ginseng Extracts |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20110028150A KR20110028150A (en) | 2011-03-17 |
KR101155967B1 true KR101155967B1 (en) | 2012-06-18 |
Family
ID=43934642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090086106A KR101155967B1 (en) | 2009-09-11 | 2009-09-11 | A health food composition for prevention and treatment of allergic rhinitis containing Germanium, elvan and red ginseng Extracts |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101155967B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180058872A (en) | 2016-11-15 | 2018-06-04 | (의료)길의료재단 | Pharmaceutical composition and functional food composition for prevention or treatment of rhinitis comprising woogonin |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060038396A (en) * | 2003-06-19 | 2006-05-03 | 최장윤 | New saponin compound, saponin solution containing the same a preparation method thereof, and pharmaceutical compositions, health foods and cosmetics containing the saponin as an active component |
-
2009
- 2009-09-11 KR KR1020090086106A patent/KR101155967B1/en not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060038396A (en) * | 2003-06-19 | 2006-05-03 | 최장윤 | New saponin compound, saponin solution containing the same a preparation method thereof, and pharmaceutical compositions, health foods and cosmetics containing the saponin as an active component |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180058872A (en) | 2016-11-15 | 2018-06-04 | (의료)길의료재단 | Pharmaceutical composition and functional food composition for prevention or treatment of rhinitis comprising woogonin |
Also Published As
Publication number | Publication date |
---|---|
KR20110028150A (en) | 2011-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103156095B (en) | Mixed feed of young broiler chickens and preparation method of feed | |
CN103504901A (en) | Traditional Chinese medicine health care pillow | |
CN104983082B (en) | A kind of antibacterial double far infrared Mrs's body building type medicated bra of anophelifuge and manufacture method thereof | |
KR100825436B1 (en) | Beauty soap composition for improving skin | |
CN106235430A (en) | A kind of medicated bra and preparation method | |
KR101155967B1 (en) | A health food composition for prevention and treatment of allergic rhinitis containing Germanium, elvan and red ginseng Extracts | |
CN104985963A (en) | Novel stationery storage device compounded by tourmaline and activated carbon | |
CN104875693A (en) | Natural mosquito repelling plant and active mineral composed automobile front-wall sound insulating pad | |
CN111838211A (en) | Mite and odor removing plant extract combined liquid, method and application | |
KR101417261B1 (en) | Korean medical composition set for improving rhinitis and empyema and manufacturing method thereof | |
KR102420144B1 (en) | Composition of clay comprising sulfur and method for producing the same | |
CN104997177B (en) | Vapor-permeable type bra that activated carbon and negative ion mineral are compounding and manufacture method | |
CN106692504A (en) | Anti-haze health food capable of clearing heat from throat, relieving cough and moistening lung and preparation method thereof | |
CN104082747A (en) | Health food with function of improving body immunity and preparation method of health food | |
WO2001056589A2 (en) | Physiologically active compositions of basidiomycotina and araliaceae extracts | |
KR101648211B1 (en) | Sasa quelpaertensis nakai tea and manufacture method thereof | |
CN105029728B (en) | A kind of have far infrared and the medicated bra of negative ion health function and manufacture method thereof | |
CN104921567B (en) | A kind of multipurpose bedroom carpet with infrared ray health care | |
CN104983088B (en) | There is broad-spectrum antiseptic type negative ion health underwear and the manufacture method thereof walking quickly and keeping away mosquito | |
KR20040064801A (en) | A manufacture method of food for eating raw | |
CN106974032A (en) | One kind five spends clear taste tea and preparation method thereof | |
CN106235429A (en) | A kind of health care underwear | |
KR102231017B1 (en) | a red clay ball for air filter which absorbed green tea ingredient | |
CN101683427B (en) | Traditional Chinese medicine composition and preparation method thereof | |
KR20120125861A (en) | Functional soap composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20160603 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20170325 Year of fee payment: 6 |
|
LAPS | Lapse due to unpaid annual fee |